Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Regeneration of Heart Tissue Induced by Cardiac Stem Cells

By LabMedica International staff writers
Posted on 09 Feb 2017
Nanoscale three-dimensional printing was used to create a scaffold for the growth of cardiovascular tissue that could be transplanted into a damaged heart following a heart attack.

The heart cannot normally regenerate muscle tissue after a heart attack has killed part of the muscle wall. More...
In order to spur the damaged heart into regenerating new tissue, investigators at the University of Alabama and the University of Minnesota used multiphoton-excited, three-dimensional printing (MPE-3DP) to generate a native-like, extracellular matrix (ECM) scaffold with submicron resolution.

This novel scaffolding was seeded with approximately 50,000 human, iPSC (induced pluripotent stem cell)-derived cardiomyocytes (CMs), smooth muscle cells (SMCs), and endothelial cells (ECs) in a 2:1:1 ratio to generate the hCMP (human, iPSC-derived cardiac muscle patch). The patch began generating calcium transients and beating synchronously within one day of seeding; the speeds of contraction and relaxation and the peak amplitudes of the calcium transients increased significantly over the next seven days.

The investigators reported in the January 9, 2017, online edition of the journal Circulation Research that when tested in mice with surgically induced myocardial infarction (MI), measurements of cardiac function, infarct size, apoptosis, both vascular and arteriole density, and cell proliferation at week four after treatment were significantly better in animals treated with the hCMPs than in animals treated with cell-free scaffolds.

The authors concluded that, “Thus, the hiPSC-derived cardiac muscle patches produced for this report may represent an important step toward the clinical use of three-dimensional-printing technology. To our knowledge, this is the first time modulated raster scanning has ever been successfully used to control the fabrication of a tissue-engineered scaffold, and consequently, our results are particularly relevant for applications that require the fibrillar and mesh-like structures present in cardiac tissue.”


Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.